Tandem Diabetes Care Inc (TNDM)
30.81
+0.07
(+0.23%)
USD |
NASDAQ |
Nov 22, 16:00
30.90
+0.09
(+0.29%)
After-Hours: 20:00
Tandem Diabetes Care Cash from Investing (Quarterly): -19.90M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -19.90M |
| June 30, 2024 | -3.54M |
| March 31, 2024 | -5.056M |
| December 31, 2023 | -16.58M |
| September 30, 2023 | -48.52M |
| June 30, 2023 | 5.698M |
| March 31, 2023 | -26.33M |
| December 31, 2022 | 35.78M |
| September 30, 2022 | -14.16M |
| June 30, 2022 | 6.357M |
| March 31, 2022 | 5.197M |
| December 31, 2021 | -76.82M |
| September 30, 2021 | -39.20M |
| June 30, 2021 | -64.76M |
| March 31, 2021 | -6.094M |
| December 31, 2020 | -59.63M |
| September 30, 2020 | -137.82M |
| June 30, 2020 | -131.52M |
| March 31, 2020 | 32.92M |
| December 31, 2019 | -20.90M |
| September 30, 2019 | -22.17M |
| June 30, 2019 | -14.66M |
| March 31, 2019 | 0.778M |
| December 31, 2018 | -6.591M |
| Date | Value |
|---|---|
| September 30, 2018 | -46.81M |
| June 30, 2018 | -27.82M |
| March 31, 2018 | -9.514M |
| December 31, 2017 | -1.419M |
| September 30, 2017 | -0.244M |
| June 30, 2017 | 1.838M |
| March 31, 2017 | 2.607M |
| December 31, 2016 | 4.575M |
| September 30, 2016 | 5.828M |
| June 30, 2016 | 1.681M |
| March 31, 2016 | -1.636M |
| December 31, 2015 | 8.86M |
| September 30, 2015 | 11.53M |
| June 30, 2015 | 0.305M |
| March 31, 2015 | -18.27M |
| December 31, 2014 | 7.509M |
| September 30, 2014 | -15.15M |
| June 30, 2014 | 2.794M |
| March 31, 2014 | -30.63M |
| December 31, 2013 | -6.575M |
| September 30, 2013 | -2.614M |
| June 30, 2013 | -0.515M |
| March 31, 2013 | -1.401M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-137.82M
Minimum
Sep 2020
35.78M
Maximum
Dec 2022
-29.24M
Average
-18.24M
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp | -1.427B |
| Masimo Corp | -13.50M |
| RxSight Inc | -9.26M |
| Perspective Therapeutics Inc | -29.74M |
| Xtant Medical Holdings Inc | -2.009M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 26.78M |
| Cash from Financing (Quarterly) | -4.519M |
| Free Cash Flow | -37.35M |
| Free Cash Flow Per Share (Quarterly) | 0.3287 |
| Free Cash Flow to Equity (Quarterly) | 21.04M |
| Free Cash Flow to Firm (Quarterly) | 21.54M |
| Free Cash Flow Yield | -1.86% |